A Phase 2a, Open-Label, Proof -of-Concept Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Intranasal Clonazepam in Adult Subjects With Epileptic Seizures.

Trial Profile

A Phase 2a, Open-Label, Proof -of-Concept Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Intranasal Clonazepam in Adult Subjects With Epileptic Seizures.

Completed
Phase of Trial: Phase II

Latest Information Update: 02 Sep 2014

At a glance

  • Drugs Clonazepam (Primary)
  • Indications Seizures
  • Focus Proof of concept; Therapeutic Use
  • Sponsors Jazz Pharmaceuticals Inc
  • Most Recent Events

    • 08 Mar 2011 According to a Jazz Pharmaceuticals SEC form 10-K Annual Report, preliminary findings of this trial were positive.
    • 11 Jun 2008 This trial is expected to be completed in 2008, according to a Jazz Pharmaceuticals media release.
    • 08 Jan 2008 FDA Orphan Drug Designation received.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top